OIP seeks to communicate FDA policy, regulatory decisions, and information about its programs to counterpart government officials and international organizations around the world. Effective communication enhances cooperation with these and other stakeholders on public health matters of mutual interest, and provides prompt, accurate, and effective responses to a wide range of requests for program, policy, and technical information.
OIP coordinates, organizes and conducts major international conferences, including annual meetings with counterpart regulatory agencies, symposia, workshops, and briefings for the embassy diplomatic corps located in Washington, D.C. in areas of specific FDA concern and/or mutual interest and benefit.
OIP serves as the Agency focal point on policies and procedures for sharing public and non-public information internationally. In this regard, OIP is the primary agency liaison with other U.S. Government components, international and foreign governments in disseminating public and non-public information concerning international notifications of recalls in the United States of products that have been also distributed abroad.
News, Announcemements, and Alerts
La FDA colabora con la OPS para poner en marcha la nueva Plataforma Regional sobre el Acceso y la Innovación de Tecnologías Sanitarias en las Américas The FDA signs cooperation agreement with the Public Health Institute of Chile Newsroom What’s New By Topic FDA Fact Sheet: Increasing FDA Capacity in China